Status:

RECRUITING

Association of a Digital Signature of Physical Activity and Sedentary Lifestyle With the Development of Multimorbidities in Chronic Diseases (eMOB)

Lead Sponsor:

University Hospital, Clermont-Ferrand

Conditions:

Exercise

Sedentary Behavior

Eligibility:

All Genders

18-90 years

Phase:

NA

Brief Summary

Physical activity (PA) and sedentary lifestyle are determinants in the development of chronic diseases and associated quality of life alterations. PA levels are correlated with quality of life and mor...

Detailed Description

Study design : eMOB study is a monocentric prospective cohort study. We aim to explore in a longitudinal study the association of a digital signature of PA and sedentary lifestyle with the developmen...

Eligibility Criteria

Inclusion Criteria:

  • Patient follow-up at CHU Clermont-Ferrand for a chronic disease in one of the following observational cohorts:

    • Inflammatory rheumatic disease(rheumatoid arthritis, spondyloarthritis) included in the RCVRIC cohort (CPP Sud-Est VI N° ID-RCB- A01847-40)
    • Pre-surgical knee and hip osteoarthritis (Evalmob) (ID-RCB N° 2019- A01017-50)
    • Major depressive disorder included in the FACE-DR cohort (CNIL agreement: DR- 2015-673) and Bipolar disorder included in the FACE-BD cohort (CPP Ile de France IX; January 18, 2010) of the Adult Psychiatry Department B
    • Type 2 diabetes included in the cohort of the sport medicine service "Rehabilitation T2" (CNIL agreement 0164)
    • Obesity included in the "Obesity" sports medicine service cohort (CNIL agreement 0164)
    • COPD included in the "COPD Rehabilitation" sports medicine service cohort (CNIL agreement 0164)
    • Chronic pain cohort (eDOL) (CPP West II N° ID-RCB 2020-A02027-32)
  • Affiliation to a social security system.

  • Able to provide written informed consent to participate in the research.

Exclusion Criteria:

  • Inability to practice physical activity
  • Pregnant or breastfeeding
  • Refusal to participate
  • Minors or adults under the protection of the law or under the protection of justice.

Key Trial Info

Start Date :

December 7 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2030

Estimated Enrollment :

700 Patients enrolled

Trial Details

Trial ID

NCT05578495

Start Date

December 7 2023

End Date

December 1 2030

Last Update

September 24 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CHU de Clermont-Ferrand

Clermont-Ferrand, France, 63000